Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study
Open Access
- 17 October 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 60 (5) , 981-990
Abstract
While advances in asthma care have been made in Latin America, there is still a large unmet need in patients with uncontrolled asthma. This post hoc analysis of the QUEST study assessed safety and ...Keywords
Funding Information
- Regeneron Pharmaceuticals
This publication has 25 references indexed in Scilit:
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialThe Lancet, 2016
- Targeting key proximal drivers of type 2 inflammation in diseaseNature Reviews Drug Discovery, 2015
- Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United StatesThe Journal of Allergy and Clinical Immunology: In Practice, 2015
- Asthma in Latin AmericaThorax, 2015
- Type 2 inflammation in asthma — present in most, absent in manyNature Reviews Immunology, 2014
- Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal miceProceedings of the National Academy of Sciences, 2014
- Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genesProceedings of the National Academy of Sciences, 2014
- Prevalencia y riesgos asociados con pacientes adultos con asma de 40 años o más de la Ciudad de México: estudio de base poblacionalSalud Pública de México, 2012
- Prevalence of asthma and other allergic conditions in Colombia 2009–2010: a cross-sectional studyBMC Pulmonary Medicine, 2012
- Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe AsthmaJournal of Allergy and Clinical Immunology, 2010